TY - JOUR AU - Ioannidis, J. P. AU - Vlachoyianoopoulos, P. G. AU - Haidich, A. B. PY - 2005 DA - 2005// TI - Mortality in systemic sclerosis: an international meta-analysis of individual patient data JO - Am J Med VL - 118 UR - https://doi.org/10.1016/j.amjmed.2004.04.031 DO - 10.1016/j.amjmed.2004.04.031 ID - Ioannidis2005 ER - TY - JOUR AU - Le Roy, E. C. AU - Black, C. AU - Fleischmajer, R. PY - 1988 DA - 1988// TI - Scleroderma (Systemic Sclerosis): classification, subsets and pathogenesis JO - J Rheumatol VL - 15 ID - Le Roy1988 ER - TY - JOUR AU - Jimenez, A. S. AU - Hitraya, E. AU - Varga, J. PY - 1996 DA - 1996// TI - Pathogenesis of scleroderma: Collagen JO - Rheum Dis Clin North Am VL - 22 UR - https://doi.org/10.1016/S0889-857X(05)70294-5 DO - 10.1016/S0889-857X(05)70294-5 ID - Jimenez1996 ER - TY - JOUR AU - Nihtyanova, S. I. AU - Denton, C. P. PY - 2008 DA - 2008// TI - Current approaches to the management of early active diffuse scleroderma skin disease JO - Rheum Dis Clin North Am VL - 34 UR - https://doi.org/10.1016/j.rdc.2007.11.005 DO - 10.1016/j.rdc.2007.11.005 ID - Nihtyanova2008 ER - TY - JOUR AU - Atra, E. AU - Goldenberg, J. AU - Sasso, W. S. PY - 1977 DA - 1977// TI - Proposição de um novo tratamento para a esclerodermia, utilizando o cloridrato de dietilamino 2,6 dimetil-acetanilida JO - Revista Brasileira de Reumatologia VL - 3 ID - Atra1977 ER - TY - JOUR AU - Keiser, H. R. AU - Stein, D. AU - Sjoerdsma, A. PY - 1971 DA - 1971// TI - Increased protocollagen proline hydroxylase activity in sclerodermatous patients JO - Arch Derm VL - 104 UR - https://doi.org/10.1001/archderm.1971.04000190059008 DO - 10.1001/archderm.1971.04000190059008 ID - Keiser1971 ER - TY - JOUR AU - Fleckman, P. H. AU - Jeffrey, J. J. AU - Eisen, A. Z. PY - 1973 DA - 1973// TI - A sensitive microassay for prolyl hydroxylase activity in normal and psoriatic skin JO - J Invest Dermatol VL - 60 UR - https://doi.org/10.1111/1523-1747.ep13069808 DO - 10.1111/1523-1747.ep13069808 ID - Fleckman1973 ER - TY - JOUR AU - Moher, D. AU - Schulz, K. F. AU - Altman, D. PY - 2001 DA - 2001// TI - The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.15.1987 DO - 10.1001/jama.285.15.1987 ID - Moher2001 ER - TY - JOUR PY - 1980 DA - 1980// TI - Preliminary criteria for the classification of systemic sclerosis (scleroderma) JO - Arthritis Rheum VL - 23 UR - https://doi.org/10.1002/art.1780230510 DO - 10.1002/art.1780230510 ID - ref9 ER - TY - JOUR AU - Clements, P. J. AU - Lachenbruch, P. A. AU - Seibold, J. R. PY - 1993 DA - 1993// TI - Skin thickness score in systemic sclerosis an assessment of interobserver variability in 3 independent studies JO - J Rheumatol VL - 20 ID - Clements1993 ER - TY - JOUR AU - Pope, J. E. AU - Bellamy, N. PY - 1993 DA - 1993// TI - Outcome measurements in scleroderma clinical trials JO - Semin Arthritis Rheum VL - 23 UR - https://doi.org/10.1016/S0049-0172(05)80024-1 DO - 10.1016/S0049-0172(05)80024-1 ID - Pope1993 ER - TY - JOUR AU - White, B. AU - Bauer, E. A. AU - Goldsmith, L. A. PY - 1999 DA - 1999// TI - Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380309 DO - 10.1002/art.1780380309 ID - White1999 ER - TY - JOUR AU - Steen, V. D. AU - Medsger, T. A. PY - 1997 DA - 1997// TI - The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time JO - Arthritis Rheum VL - 40 UR - https://doi.org/10.1002/art.1780401110 DO - 10.1002/art.1780401110 ID - Steen1997 ER - TY - JOUR AU - Sulli, A. AU - Secchi, M. E. AU - Pizzorni, C. PY - 2008 DA - 2008// TI - Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.079756 DO - 10.1136/ard.2007.079756 ID - Sulli2008 ER - TY - JOUR AU - Cutolo, M. AU - Matucci-Cerinic, M. PY - 2007 DA - 2007// TI - Nailfold capillaroscopy and classification criteria for systemic sclerosis JO - Clin Exp Rheumatol VL - 25 ID - Cutolo2007 ER - TY - JOUR AU - Sütő, G. AU - Czirják, L. PY - 2009 DA - 2009// TI - Oesophageal involvement in scleroderma JO - Clin Exp Rheumatol VL - 27 ID - Sütő2009 ER - TY - CHAP AU - Kowal-Bielecka, O. AU - Landewé, R. AU - Avouac, J. PY - 2009 DA - 2009// TI - EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) BT - Ann Rheum Dis ID - Kowal-Bielecka2009 ER - TY - JOUR AU - Jadad, A. R. AU - Moore, R. A. AU - Carroll, D. PY - 1996 DA - 1996// TI - Assessing the quality of reports of randomized clinical trials: Is blinding necessary? JO - Controlled Clinical Trials VL - 17 UR - https://doi.org/10.1016/0197-2456(95)00134-4 DO - 10.1016/0197-2456(95)00134-4 ID - Jadad1996 ER - TY - BOOK PY - 2008 DA - 2008// TI - Chapter 8: Assessing the risk of bias in included studies. Cochrane Handbook for systematic reviews of interventions. ID - ref19 ER - TY - STD TI - Phillips B, Ball C, Sackett D: Oxford Centre of Evidence-based Medicine - Levels of Evidence(March 2009). Centre for Evidence based Medicine [http://www.cebm.net/index.aspx?o=1025], 2010 (Mar 22). UR - http://www.cebm.net/index.aspx?o=1025 ID - ref20 ER -